When in a drug epidemic should the policy objective switch from use reduction to harm reduction? (Q1044171): Difference between revisions
From MaRDI portal
Removed claims |
Changed an Item |
||
| Property / author | |||
| Property / author: Jonathan P. Caulkins / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Gustav Feichtinger / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Gernot Tragler / rank | |||
Normal rank | |||
Revision as of 20:31, 9 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | When in a drug epidemic should the policy objective switch from use reduction to harm reduction? |
scientific article |
Statements
When in a drug epidemic should the policy objective switch from use reduction to harm reduction? (English)
0 references
10 December 2009
0 references
OR in societal problem analysis
0 references
control
0 references
health
0 references
drug policy
0 references
epidemics
0 references
